Johannes Gerardus Christiaan Petrus Schikan - 22 Sep 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Sep 2026, 10:43:33 UTC
Prior SEC filing
21 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marnus Nel, Attorney-in-Fact for Johannes Schikan

Key filing fact

Johannes Gerardus Christiaan Petrus Schikan filed Form 4 for Pharvaris N.V. (PHVS) on 24 Sep 2026.

Key facts

  • This page summarizes Johannes Gerardus Christiaan Petrus Schikan's Form 4 filing for Pharvaris N.V. (PHVS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Sep 2026, 10:43.

Change

  • Previous filing in this sequence was filed on 21 Sep 2026.
  • Current net transaction value: -$28,952.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002014983 Primary reporting owner

Schikan Johannes Gerardus Christiaan Petrus

Relationship
Director
Address
1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature
/s/ Marnus Nel, Attorney-in-Fact for Johannes Schikan
Signature date
24 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares
+800
Change %
+0.69%
Price
$20.00*
Shares after
115,967
Date
22 Sep 2026
Ownership
Direct
PHVS transaction

Common Stock

Sale

Transaction value
$28,952
Shares
-800
Change %
-0.69%
Price
$36.19
Shares after
115,167
Date
22 Sep 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-800
Change %
-2.3%
Price
$0.000000*
Shares after
34,200
Date
22 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
800
Exercise price
$20.00
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $36.15 to $36.23. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F2

25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .